Review of Intravenous Selenium Infusions for the Critically III Patient

Abstract

Attempts to improve mortality for patients with sepsis, severe sepsis, systemic inflammatory response syndrome, and septic shock continue to challenge health care professionals. This review will explore how the antioxidant, and possibly pro-oxidant, properties of selenium may benefit critically ill patients. Literature examining improvements in clinical outcomes from intravenous (IV) selenium infusion therapy will be discussed. Although there is not an overwhelming amount of knowledge about IV selenium and its effect on morbidity and mortality, this review will outline recent research evaluating the use of IV selenium infusions and its potential to decrease morbidity and mortality for different critically ill patient populations.

Get full access to this article

View all access options for this article.

References

Heyland

D.K.

Dhaliwal

Ulrich

Antioxidant nutrients: a systemic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005; 31: 327–337.

Angstwurm

M.W.

Engelmann

Zimmermann

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007; 35: 118–126.

Dellinger

R.P.

Levy

M.M.

Carlet

J.M.

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296–327.

Mishra

Baines

Perry

S.E.

Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007; 26: 41–50.

Manzanares

Biestro

Torre

M.H.

High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011; 37: 1120–1127.

Vincent

J.L.

Forceville

Critically elucidating the role of selenium. Curr Opin Anesthesiol. 2008; 21: 148–154.

Forceville

Laviolle

Annane

Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007; 11: R73.

Angstwurm

M.W.

Schottdorf

Schopohl

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999; 27: 1807–1813.

Valenta

Brodska

Drabek

High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med. 2011; 37: 808–815.

10.

Collier

B.R.

Giladi

Dossett

L.A.

Impact of high-dose antioxidants on outcomes in acutely injured patients. J Parenter Enteral Nutr. 2008; 32: 384–388.

11.

Giladi

A.M.

Dossett

L.A.

Fleming

S.B.

High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Injury. 2011; 42: 78–82.

12.

Soguel

Chiotero

R.L.

Ruffieux

Berger

M.M.

Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients. Nutrition. 2008; 24: 1123–1132.

13.

Sprung

C.L.

Annane

Keh

Hydrocortisone therapy for patients with septic shock (CORTICUS). N Engl J Med. 2008; 358: 111–124.

14.

Berger

M.M.

Baines

Raffoul

Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007; 85: 1293–1300.

15.

Manzanares

Hardy

Selenium supplementation in the critically ill: posology and pharmacokinetics. Curr Opin Clin Nutr Metabolic Care. 2009; 12: 273–280.

16.

Heyland

D.K.

Dhaliwal

Day

A.G.

Reducing Deaths due to Oxidative Stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically ill patients. Proc Nutr Soc. 2006; 65: 250–263.